SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950149-04-000411
Filing Date
2004-02-17
Accepted
2004-02-17 13:42:15
Documents
1
Group Members
ANSBERT GADICKEBAB BIOVENTURES L.P.BAB BIOVENTURES, N.V.BB BIOVENTURES L.P.LUKE EVNINMEDICAL PORTFOLIO MANAGEMENT, LLCMICHAEL STEINMETZMPM ASSET MANAGEMENT INVESTORS 1998 LLCMPM ASSET MANAGEMENT LLCMPM BIOVENTURES I LLCMPM BIOVENTURES I LPMPM BIOVENTURES

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G f96573sc13g.htm SC 13G 149884
  Complete submission text file 0000950149-04-000411.txt   152294
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Subject) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: SC 13G | Act: 34 | File No.: 005-34935 | Film No.: 04606761
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address ONE CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address ONE CAMBRIDGE CENTER CAMBRIDGE MA 02142 6172257054
MPM CAPITAL LP (Filed by) CIK: 0001134654 (see all company filings)